Blood & Plasma Components Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Products (Packed Red Blood Cells, Platelets Products, Frozen Plasma, Plasma Derived Products), By Application (Hematology, Solid Tumor Management, Others), By End User (Hospitals & Clinics, Diagnostic Laboratories, Others), By company and By Region

The global blood & plasma components market is anticipated to observe impressive growth during the forecast period, 2023-2027. The major factors include growing volume of surgeries, surge in the prevalence of trauma and road accidents, and increase in number of people from chronic conditions including cancer are curbing the growth of the market. Blood is life-sustaining fluid that flows throughout the body giving nourishment, electrolytes, hormones, antibodies, and vitamins to body tissues. Plasma is a part of blood which is aqueous in nature, it contains salt and proteins in which platelets, white blood cells and red blood cells are suspended. The other factors supporting the market’s growth are, rising awareness associated with the significance of blood donations, high patient pool, government initiatives, increasing investments for research and development activities, several blood donation campaigns undertaken by various blood organizations, rise in the elderly population base, rise in R&D activities, and technological advancements. Also, the strategic initiatives such as partnerships and product launches undertaken by the market players are augmenting the growth of the market.

Increasing Occurrence of Trauma and Road Accidents

Rising Frequency of Blood Diseases and Surgeries

Increasing Adoption of Inorganic Growth Strategies

Download Free Sample Report

Market Segmentation

Market Players

CSL Limited, Grifols S.A., ADMA Biologics, Inc., Takeda Pharmaceutical Company Limited, Octapharma AG, Kedrion S.p.A, Emergent BioSolutions Inc., Bio Products Laboratory Ltd., LFB S.A., and Versiti, Inc.